Published in Clin Endocrinol (Oxf) on July 01, 1974
Concurrence of Grave's disease and Hashimoto's thyroiditis. Arch Dis Child (1977) 0.90
Human leukocyte antigen (HLA) in Korean patients with autoimmune thyroid diseases. Korean J Intern Med (1986) 0.81
Somatostatin: a paracrine contribution to hypothyroidism in Hashimoto's thyroiditis. J Clin Pathol (1982) 0.79
Histometry of lymphoid infiltrate in the thyroid of primary thyrotoxicosis patients. Relation of extent of thyroiditis to preoperative drug treatment and postoperative hypothyroidism. J Clin Pathol (1976) 0.78
Dysthyroid ophthalmopathy: an update. J Natl Med Assoc (1979) 0.75
Editorial: hyperthyroidism and Grave's disease. Br Med J (1975) 0.75
The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med (1989) 4.41
The spectrum of renal disease in Laurence-Moon-Biedl syndrome. N Engl J Med (1988) 2.36
Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet (1989) 2.03
Circulating viral and thyroid antibodies in subacute thyroiditis. J Clin Endocrinol Metab (1967) 2.01
Retracted Peripheral thymus-dependent (T) lymphocytes in Graves's disease and Hashimoto's thyroiditis. N Engl J Med (1973) 1.68
Telephone modem access improves diabetes control in those with insulin-requiring diabetes. Diabetes Care (1992) 1.63
Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis. Clin Endocrinol (Oxf) (1993) 1.57
Riedel's thyroiditis associated with Hashimoto's thyroiditis, hypoparathyroidism, and retroperitoneal fibrosis. J Endocrinol Invest (1991) 1.51
The pathogenesis of Graves' disease. A disorder of delayed hypersensitivity? Mayo Clin Proc (1972) 1.44
Does smoking increase relapse rates in Graves' disease? J Endocrinol Invest (2002) 1.40
Immunology of autoimmune thyroid diseases. N Engl J Med (1982) 1.38
Hashimoto's thyroiditis is associated with HLA-DRw3. N Engl J Med (1978) 1.37
Suppressor T-lymphocyte deficiency in Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab (1981) 1.31
Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. J Clin Endocrinol Metab (1973) 1.30
Studies of serum triiodothyronine concentration in maternal and cord blood: transfer of triiodothyronine across the human placenta. J Clin Endocrinol Metab (1969) 1.29
The role of autoimmunity in hypoendocrine and hyperendocrine function: with special emphasis on autoimmune thyroid disease. Ann Intern Med (1977) 1.28
Gm phenotypes in autoimmune thyroid disease. J Immunogenet (1977) 1.28
The human major histocompatibility complex and endocrine disease. Endocr Rev (1981) 1.25
A study of human leukocyte D locus related antigens in Graves' disease. J Clin Invest (1979) 1.21
High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area. Cancer Res (1991) 1.14
HLA-D--related (DRw) antigens in juvenile diabetes mellitus. Diabetes (1979) 1.12
T cell antigen receptors in autoimmunity. J Immunol (1988) 1.11
Immunologic aspects of Graves' and Hashimoto's diseases. Metabolism (1980) 1.08
Rosette inhibition test for the demonstration of thymus-dependent lymphocyte sensitization in Grave's disease and Hashimoto's thyroiditis. N Engl J Med (1973) 1.07
Effects of cytokine-mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells. Int J Cancer (1995) 1.06
The pathogenesis of Graves' disease: an overview. Clin Endocrinol Metab (1978) 1.06
Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease. J Clin Endocrinol Metab (1978) 1.05
Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF). J Clin Endocrinol Metab (1973) 1.05
S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma. Br J Cancer (2005) 1.05
Lack of significant binding of L-triiodothyronine by thyroxine-binding globulin in vivo as demonstrated by acute disappearance of 131-I-labeled triiodothyronine. J Clin Invest (1966) 1.04
Thyroid autoimmune disease in a large Newfoundland family: the influence of HLA. J Clin Endocrinol Metab (1977) 1.02
Biological activity of anti-thyrotropin anti-idiotypic antibody. Eur J Immunol (1983) 1.01
Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders. J Clin Endocrinol Metab (1979) 1.00
The association of goitrous autoimmune thyroiditis with HLA-DR5. Tissue Antigens (1981) 1.00
Haemodialysis in paracetamol self-poisoning. Lancet (1972) 1.00
Subacute (de Quervain's) thyroiditis. Clin Endocrinol Metab (1979) 0.99
The association of HLA--B8 with atrophic thyroiditis. Tissue Antigens (1979) 0.98
Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease. J Clin Endocrinol Metab (1986) 0.98
Graves' disease and HLA: clinical and epidemiologic associations. Clin Endocrinol (Oxf) (1980) 0.98
Blood coagulation and fibrinolysis in thyroid disease. Thromb Haemost (1976) 0.97
Letter: Proportion of E rosettes normal in Graves's and Hashimoto's disease: a retraction. N Engl J Med (1975) 0.96
The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab (1985) 0.96
Polymorphism of the T cell receptor beta-chain in Graves' disease. J Clin Endocrinol Metab (1987) 0.95
Evidence for cell-mediated immunity and specific suppressor T lymphocyte dysfunction in Graves' disease and diabetes mellitus. J Clin Endocrinol Metab (1983) 0.94
High levels of Nm23 gene expression in advanced stage of thyroid carcinomas. Br J Cancer (1993) 0.94
HLA haplotypes in familial Graves' disease. Tissue Antigens (1980) 0.93
HLA and autoimmune endocrine disease 1985. Mol Biol Med (1986) 0.93
Immunoregulation in autoimmune thyroid disease. N Engl J Med (1987) 0.92
The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease. Tissue Antigens (1976) 0.91
p53 mutations in all stages of thyroid carcinomas. J Clin Endocrinol Metab (1993) 0.91
The pathology of thyroiditis. Hum Pathol (1978) 0.91
Cytogenetic analyses of three papillary carcinomas and a follicular adenoma of the thyroid. Cancer Genet Cytogenet (1990) 0.91
Serum lipids in hypothyroidism--a re-evaluation. J Clin Endocrinol Metab (1978) 0.91
Evidence that antithyroid drugs induce remissions in Graves' disease by modulating thyroid cellular activity. Clin Endocrinol (Oxf) (1986) 0.90
Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9. Biochem J (2000) 0.90
Utilization of luteinizing hormone-releasing hormone agonist in pulmonary leiomyomatosis. Fertil Steril (1987) 0.89
Studies on the immunoregulation of thyroid autoantibody production in vitro. Clin Exp Immunol (1985) 0.88
Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors. Cell Mol Biol (Noisy-le-grand) (2005) 0.88
Properdin factor B(Bf) allele BfF1 specifies an HLA-B18 diabetogenic haplotype. Diabetes (1980) 0.88
Association of IRF5 gene polymorphisms with rheumatoid arthritis in a Tunisian population. Scand J Rheumatol (2008) 0.88
FHIT gene abnormalities in both benign and malignant thyroid tumours. Eur J Cancer (1999) 0.87
Two HLA DRB 1 alleles confer independent genetic susceptibility to Graves disease: relevance of cross-population studies. Am J Med Genet (2001) 0.87
Spontaneous secretion of thyroid autoantibodies by cultured peripheral blood lymphocytes from patients with Hashimoto's thyroiditis detected by micro-ELISA techniques. Clin Exp Immunol (1984) 0.87
Increased requirement for thyroid hormone after a jejunoileal bypass operation. Can Med Assoc J (1980) 0.87
The expression of the MDM2 gene, a p53 binding protein, in thyroid carcinogenesis. Cancer (1995) 0.87
Letter: E-rosette inhibition test of T-lymphocyte sensitization. Br Med J (1974) 0.86
The metabolic significance of thyroxine-binding globulin. Studies in a family with decreased thyroxine-binding globulin. Acta Endocrinol (Copenh) (1969) 0.86
Action of globulin and lymphocytes from peripheral blood of patients with Graves' disease on isolated bovine thyroid cells. J Clin Endocrinol Metab (1970) 0.86
Seroreactivity to bacterial antigens is not a unique phenomenon in patients with autoimmune thyroid diseases in Canada. Thyroid (1994) 0.86
Further studies on the rate of disappearance of labelled thyroxine from the intravascular compartment of man, with reference to the role of thyroxine binding proteins. Acta Endocrinol (Copenh) (1967) 0.86
Antiidiotypic antibodies as probes for receptor structure and function. Endocr Rev (1985) 0.86
Human minimal androgen insensitivity with normal dihydrotestosterone-binding capacity in cultured genital skin fibroblasts: evidence for an androgen-selective qualitative abnormality of the receptor. Am J Hum Genet (1984) 0.86
Etiology, pathogenesis, and clinical aspects of thyroiditis. Pathol Annu (1978) 0.86
The influence of liver damage in man on the distribution and disposal rates of thyroxine and triiodothyronine. J Clin Endocrinol Metab (1972) 0.85
Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia. Cancer (1994) 0.85
Soluble interleukin-2 receptor in sera of patients with Graves' disease. J Autoimmun (1991) 0.84
Thyroid antigen stimulates lymphocytes from patients with Graves' disease to produce thyroid-stimulating immunoglobulin (TSI). J Clin Endocrinol Metab (1976) 0.84
The association of HLA with juvenile diabetes mellitus in Newfoundland. Tissue Antigens (1978) 0.84
Polyglandular autoimmune disease and HLA. Tissue Antigens (1980) 0.84
The role of HLA antigens in the manifestation and course of Graves' disease. Mol Biol Med (1986) 0.84
HLA-DR associations with Graves' disease in eastern Hungary. Clin Invest Med (1983) 0.84